Linked Data API

Show Search Form

Search Results

1581123
star this property registered interest false more like this
star this property date less than 2023-01-26more like thismore than 2023-01-26
star this property answering body
Department for Business, Energy and Industrial Strategy more like this
unstar this property answering dept id 201 more like this
unstar this property answering dept short name Business, Energy and Industrial Strategy remove filter
star this property answering dept sort name Business, Energy and Industrial Strategy more like this
star this property hansard heading Voluntary Scheme for Branded Medicines Pricing and Access: Innovation and Research more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Business, Energy and Industrial Strategy, what assessment he has made of the potential effect of the Voluntary Scheme for Branded Medicines Pricing Access on (a) global R&D investment decisions and (b) access to medical innovation. remove filter
star this property tabling member constituency Cambridge more like this
star this property tabling member printed
Daniel Zeichner more like this
star this property uin 133601 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer less than 2023-01-31more like thismore than 2023-01-31
star this property answer text <p>The Government is working to better understand the impacts the operation of the current Voluntary Scheme on investments in the UK and access to medicines. We are therefore in direct conversations with companies to understand these impacts. The Department for Business, Energy and Industrial Strategy is in close discussions with the Department of Health and Social Care, the Department responsible for the Voluntary Scheme, about the business environment for life sciences and its impact on investment and patient access.</p> more like this
star this property answering member constituency Wealden more like this
star this property answering member printed Ms Nusrat Ghani more like this
star this property question first answered
less than 2023-01-31T14:29:06.043Zmore like thismore than 2023-01-31T14:29:06.043Z
star this property answering member
4460
star this property label Biography information for Ms Nusrat Ghani remove filter
star this property tabling member
4382
unstar this property label Biography information for Daniel Zeichner more like this